See also this year's filing and all EDGAR filings for this company.
PDF Report 0001176309_2026_Oramed_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001176309, Oramed Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 133,271,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 586,000 |
| 3 | remainder_Assets | 97,007,000 |
| 4 | LiabilitiesCurrent | 19,086,000 |
| 5 | LiabilitiesNoncurrent | 12,034,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 1,521,689 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,096,707 |
| 9 | ResearchAndDevelopmentExpense | 6,384,107 |
| 10 | remainder_Expenses | 47,605,992 |
| 11 | remainder_Revenues | 3,145,079 |
| 12 | remainder_NetIncome | -1,971,078 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 230,864,000 |
| 1 | Liabilities | 31,120,000 |
| 2 | Expenses | 63,608,495 |
| 3 | Revenues | 3,145,079 |
| 4 | StockholdersEquity | 199,744,000 |
| 5 | NetIncome | -62,434,494 |
| 6 | ComprehensiveNetIncome | -62,434,494 |
| 7 | BaseVar | 165,354,326 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.85 |
| 9 | EconomicCapitalRatio | 3.58 |
Edgar->Model Mapping
Feature Distribution
Change over Time
